ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas

Oncogene

Volumn 31, Issue 45, 2012, Pages 4778-4788

  Colas, E ^a,g   Muinelo Romay, L ^b   Alonso Alconada, L ^b   Llaurado, M ^a   Monge, M ^a   Barbazan, J ^b   Gonzalez, M ^a   Schoumacher, M ^c   Pedrola, N ^a   Ertekin, T ^a   Devis, L ^a   Ruiz, A ^a   Castellvi, J ^a   Doll, A ^a   Gil Moreno, A ^a,g   Vazquez Levin, M ^d   Lapyckyj, L ^d   Lopez Lopez, R ^b   Robine, S ^c   Friederich, E ^e   Castro, M ^f   Reventos, J ^a   Vignjevic, D ^c   Abal, M ^a,b   more..

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

^c CNRS   (France)

^d Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^e UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^f UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Carcinoma invasion; EMT; Endometrial cancer; ETV5; LPP

Indexed keywords

CYTOSKELETON PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV5; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL LINE; CELL MIGRATION; ENDOMETRIUM CARCINOMA; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TUMOR MICROENVIRONMENT;

CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LIM DOMAIN PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84869090556     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.632     Document Type: Article

References (43)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA A Cancer J Clinicians 2010; 60: 277-300.
2. Abal M, Llaurado M, Doll A, Monge M, Colas E, Gonzalez M et al. Molecular determinants of invasion in endometrial cancer. Clin Transl Oncol 2007; 9: 272-277.
3. Radisky DC, Kenny PA, Bissell MJ. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem 2007; 101: 830-839. (Pubitemid 47040865)
4. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142. (Pubitemid 43278296)
5. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
6. Thiery JP, Morgan M. Breast cancer progression with a Twist. Nat Med 2004; 10: 777-778. (Pubitemid 39070843)
7. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118: 277-279. (Pubitemid 39061108)
8. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4: 839-849. (Pubitemid 39472951)
9. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332-337. (Pubitemid 39551661)
10. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-428. (Pubitemid 46809165)
11. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Biol 2002; 3: 155-166.
12. Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 2004; 48: 365-375. (Pubitemid 39360388)
13. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-939. (Pubitemid 38798858)
14. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14: 818-829. (Pubitemid 351757205)
15. Sivridis E. Angiogenesis and endometrial cancer. Anticancer Res 2001; 21: 4383-4388. (Pubitemid 34240969)
16. Tsukamoto H, Shibata K, Kajiyama H, Terauchi M, Nawa A, Kikkawa F. Uterine smooth muscle cells increase invasive ability of endometrial carcinoma cells through tumor-stromal interaction. Clin Exp Metastasis 2007; 24: 423-429. (Pubitemid 47367684)
17. Planaguma J, Abal M, Gil-Moreno A, Diaz-Fuertes M, Monge M, Garcia A et al. Upregulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma. J Pathol 2005; 207: 422-429. (Pubitemid 43025690)
18. Planaguma J, Diaz-Fuertes M, Gil-Moreno A, Abal M, Monge M, Garcia A et al. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma. Cancer Res 2004; 64: 8846-8853. (Pubitemid 39665488)
19. de Launoit Y, Baert JL, Chotteau-Lelievre A, Monte D, Coutte L, Mauen S et al. The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis. Biochim Biophys Acta 2006; 1766: 79-87. (Pubitemid 44202569)
20. Graves BJ, Petersen JM. Specificity within the ets family of transcription factors. Adv Cancer Res 1998; 75: 1-55. (Pubitemid 28429032)
21. Monge M, Colas E, Doll A, Gonzalez M, Gil-Moreno A, Planaguma J et al. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer. Cancer Res 2007; 67: 6753-6759. (Pubitemid 47105522)
22. Monge M, Colas E, Doll A, Gil-Moreno A, Castellvi J, Diaz B et al. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress. Carcinogenesis 2009; 30: 1288-1297.
23. Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin CH, Moustakas A. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J cell Biol 2006; 174: 175-183. (Pubitemid 44079853)
24. Muinelo-Romay L, Colas E, Barbazan J, Alonso-Alconada L, Alonso-Nocelo M, Bouso M et al. High risk endometrial carcinoma profiling identifies TGF-{beta}1 as a key factor in the initiation of tumor invasion. Mol Cancer Ther 2011; 10: 1357-1366.
25. Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M et al. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res 2008; 68: 2329-2339. (Pubitemid 351521807)
26. Stoletov K, Kato H, Zardouzian E, Kelber J, Yang J, Shattil S et al. Visualizing extravasation dynamics of metastatic tumor cells. J Cell Sci 2010; 123: 2332-2341.
27. Guo B, Sallis RE, Greenall A, Petit MM, Jansen E, Young L et al. The LIM domain protein LPP is a coactivator for the ETS domain transcription factor PEA3. Mol Cell Biol 2006; 26: 4529-4538. (Pubitemid 43877573)
28. Eo J, Han K, K MM, Song H, Lim HJ. Etv5, an ETS transcription factor, is expressed in granulosa and cumulus cells and serves as a transcriptional regulator of the cyclooxygenase-2. J Endocrinol 2008; 198: 281-290.
29. Prat J. Prognostic parameters of endometrial carcinoma. Human Pathol 2004; 35: 649-662. (Pubitemid 38881074)
30. Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4: 118-132. (Pubitemid 38198740)
31. Hurt EM, Saykally JN, Anose BM, Kalli KR, Sanders MM. Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights. Mol Cell Biochem 2008; 318: 89-99.
32. Castilla MA, Moreno-Bueno G, Romero-Perez L, Van De Vijver K, Biscuola M, Lopez-Garcia MA et al. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol 2011; 223: 72-80.
33. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
34. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674.
35. Llaurado M, Abal M, Castellvi J, Cabrera S, Gil-Moreno A, Perez-Benavente A et al. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells. Int J Cancer 2011. e-pub ahead of print 25 April 2011; doi:10.1002/ijc.26148.
36. Petit MM, Fradelizi J, Golsteyn RM, Ayoubi TA, Menichi B, Louvard D et al. LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity. Mol Biol Cell 2000; 11: 117-129. (Pubitemid 30075510)
37. Petit MM, Meulemans SM, Van de Ven WJ. The focal adhesion and nuclear targeting capacity of the LIM-containing lipoma-preferred partner (LPP) protein. J Biol Chem 2003; 278: 2157-2168. (Pubitemid 36801281)
38. Swart GW, Lunter PC, Kilsdonk JW, Kempen LC. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration? Cancer Metastasis Rev 2005; 24: 223-236. (Pubitemid 40922796)
39. Tavora B, Batista S, Reynolds LE, Jadeja S, Robinson S, Kostourou V et al. Endothelial FAK is required for tumour angiogenesis. EMBO Mol Med 2010; 2: 516-528.
40. Chacon MR, Fazzari P. FAK: dynamic integration of guidance signals at the growth cone. Cell Adh Migr 2011; 5: 52-55.
41. Monge M, Doll A, Colas E, Gil-Moreno A, Castellvi J, Garcia A et al. Subtractive proteomic approach to the endometrial carcinoma invasion front. J Proteome Res 2009; 8: 4676-4684.
42. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
43. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article 3.